Glycorex Transplantation
0.998 SEK +9.43%Be the first to follow this company
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Revenue
29.96M
EBIT %
-101.07 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NGM Main Regulated
GTAB B
Daily low / high price
0.816 / 1
SEK
Market cap
73.71M SEK
Turnover
4.45K SEK
Volume
4.7K
Financial calendar
Interim report
2024-05-23
General meeting
2024-05-29
Interim report
2024-08-29
Interim report
2024-11-28
ShowingAll content types
Glycorex Transplantation AB (GTAB B): Bokslutskommuniké 2023
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools